Home LiteratureArticle Details
PMID: 1028169 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Expression of transformation in cell hybrids. I. Isolation and application of density-inhibited Balb/3T3 cells deficient in hypoxanthine phosphoribosyltransferase and resistant to ouabain.

Somatic cell genetics ·Vol. 2 ·No. 3 ·1976-05-00 ·Pages 215-23

Jha KK, Ozer HL

Abstract

A cell line, THO2, was isolated from Balb/3T3 clone A31 after sequential nitrosoguanidine treatments and selection for resistance to 6-thioguanine and ouabain. THO2 retains the properties of density-dependent inhibition of growth and serum dependence of DNA synthesis characteristic of 3T3. The codominant expression of ouabain resistance and inability of THO2 to utilize exogenous hypoxanthine in the presence of aminopterin allows isolation of somatic cell hybrids involving THO2 and any ouabain-sensitive, hypoxanthine phosphoribosyltransferase-positive cell line. Hybrid clones derived from THO2 and SV40-transformed cells show dominant expression of the transformed phenotype with respect to multilayered arrangement of cells and ability to synthesize DNA in 1% calf-serum medium.

MeSH Terms
Cell Line Contact Inhibition DNA/biosynthesis Drug Resistance Hybrid Cells Hypoxanthine Phosphoribosyltransferase/metabolism Ouabain/pharmacology Phenotype Thioguanine/pharmacology Transformation, Genetic
Chemicals
Ouabain DNA Hypoxanthine Phosphoribosyltransferase Thioguanine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Jha K K
Ozer H L
Article Info
Journal
Somatic cell genetics
Abbr.
Somatic Cell Genet
ISSN
0098-0366
Published
1976-05-00
Pages
215-23
Language
English
Region
United States
NLM ID
7506054
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com